Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
Mintz Member Scott Lashway Recognized in Lawdragon’s 2025 List of 500 Top Global Cyber Lawyers
May 12, 2025
Lawdragon named Mintz Member and Privacy & Cybersecurity Co-chair Scott Lashway to its 2025 list of the “500 Leading Global Cyber Lawyers.” The list recognizes “world leaders in privacy, data, security, incident response, and the deals and lawsuits that revolve around all things Cyber.”
Erek Barron's arrival to Mintz as a Member in the firm’s Washington, DC office was featured in Maryland Matters. Erek joins Mintz’s White Collar Defense & Government Investigations Practice and will lead the firm’s Crisis Management and Strategic Response team.
The Daily Record covered the arrival of former US Attorney for the District of Maryland, Erek Barron, to Mintz as a White Collar Defense & Government Investigations Member in the firm’s Washington, DC office.
Fed. Circ. Won't Revive Sydnexis Eye Drop Patents
May 12, 2025
Law360 recently quoted Thomas Wintner, Chair of Mintz’s Intellectual Property Litigation Practice, on the Federal Circuit’s decision to uphold the Patent Trial and Appeal Board’s ruling that invalidated Sydnexis Inc.’s eye-drop patents. Tom, along with Member Peter Cuomo and Associate William Dixon, represented Eyenovia Inc. in challenging the patents.
Erek L. Barron, the former United States Attorney for the District of Maryland, has joined Mintz as Member in the firm’s White Collar Defense & Government Investigations Practice. He will also lead Mintz’s Crisis Management and Strategic Response team, and his practice will include complex civil, criminal, and regulatory matters. He will be resident in the Washington, DC office and in Maryland.
Member Theresa Carnegie was quoted in a Managed Healthcare Executive article about the implications of a new law in Arkansas, which bans PBMs from owning pharmacies. The law is intended to improve access and affordability for patients, but it could lead to adverse effects.